Search results
Results From The WOW.Com Content Network
Lomustine was approved by the FDA to treat high-grade gliomas in 1976. Lomustine, alone or in combination with other chemotherapeutic drugs, was the standard of care following surgery and/or radiation up until the early twenty-first century. In the United States, lomustine is currently approved for recurrent high-grade gliomas. [23]
Pituitary gland tumors are very common in the canine. A productive form arising from the anterior pituitary is the primary cause of Cushing's disease of dogs. This tumor causes excessive production of cortisol from the adrenal cortex which leads to the classic signs of alopecia (hair loss), polyuria (excessive urination), polydipsia (excessive water drinking), and a pot-bellied appearance of ...
PDX models of glioblastoma (GBM) have been essential for improving our understanding of the disease both in preclinical and translational research. [29] In vitro cell culture models of glioblastoma, although valuable, can not fully replicate the complexity of the disease since there is a clear lack of the brain microenvironment and clonal ...
Schematic block diagram of an adaptive design for a clinical trial [1] In an adaptive design of a clinical trial, the parameters and conduct of the trial for a candidate drug or vaccine may be changed based on an interim analysis. [2] [1] [3] Adaptive design typically involves advanced statistics to interpret a clinical trial endpoint. [1]
Clinical trials testing potential medical products are commonly classified into four phases. The drug development process will normally proceed through all four phases over many years. [1] When expressed specifically, a clinical trial phase is capitalized both in name and Roman numeral, such as "Phase I" clinical trial. [1]
A glioma is a type of primary tumor that starts in the glial cells of the brain or spinal cord.They are cancerous but some are extremely slow to develop. [2] [3] Gliomas comprise about 30 percent of all brain tumors and central nervous system tumours, and 80 percent of all malignant brain tumours.
Shelters use temperament tests to help identify dogs with problem behaviors, including aggression, and to help increase the rate of successful adoptions. [11] For some, these tests are a way to determine if a dog should even be offered for adoption, or to whom they will restrict adoption of an individual dog (adult-only household or sanctuary only, versus family with children).
Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain, and has a very poor prognosis for survival. [6] [7] [8] Initial signs and symptoms of glioblastoma are nonspecific. [1]